- Clinical Trials
- April 2025
- 40 Pages
Global
From €1149EUR$1,250USD£979GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1149EUR$1,250USD£979GBP
- Report
- December 2024
- 30 Pages
Global
From €2988EUR$3,250USD£2,546GBP
- Report
- August 2024
- 150 Pages
Global
From €3447EUR$3,750USD£2,938GBP
- Report
- July 2024
- 150 Pages
Global
From €3447EUR$3,750USD£2,938GBP
- Report
- July 2024
- 150 Pages
Global
From €3447EUR$3,750USD£2,938GBP
- Report
- July 2024
- 100 Pages
Global
From €3447EUR$3,750USD£2,938GBP
- Report
- June 2024
- 200 Pages
Global
From €7308EUR$7,950USD£6,229GBP
- Report
- February 2024
- 30 Pages
Global
From €2988EUR$3,250USD£2,546GBP
- Report
- January 2024
- 189 Pages
Global
From €6894EUR$7,500USD£5,876GBP
- Report
- November 2023
- 30 Pages
Global
From €2528EUR$2,750USD£2,155GBP
- Report
- November 2023
- 30 Pages
Global
From €2528EUR$2,750USD£2,155GBP
- Report
- November 2023
- 30 Pages
Global
From €2528EUR$2,750USD£2,155GBP
- Report
- February 2023
- 107 Pages
Global
From €6894EUR$7,500USD£5,876GBP
- Report
- February 2023
- 50 Pages
Global
From €3631EUR$3,950USD£3,095GBP
- Report
- May 2026
- 200 Pages
Canada
From €2564EUR$2,789USD£2,185GBP
- Report
- July 2025
- 350 Pages
Global
From €4549EUR$4,949USD£3,877GBP
- Report
- July 2025
- 200 Pages
India
From €2564EUR$2,789USD£2,185GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2564EUR$2,789USD£2,185GBP
- Report
- June 2025
- 150 Pages
Global
From €2481EUR$2,699USD£2,115GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more